莫春梅,韦 华

颈动脉粥样硬化作为引发缺血性脑卒中的关键，其发生发展与炎症反应和脂质代谢紊乱密切相关。单核细胞是固有免疫的主要成分，在AS发生发展中起着关键作用,高密度脂蛋白胆固醇（highdensity lipoprotein，HDL-C）具有逆转胆固醇运输、抗氧化、抗炎等功能。单核细胞与高密度脂蛋白胆固醇比值（MHR）是衡量脂质代谢和炎症的新型生物标志物，本文就MHR与颈动脉粥样硬化性疾病的关系进行综述，以期为临床诊治动脉粥样硬化性疾病提供新思路。

单核细胞、高密度脂蛋白胆固醇、单核细胞/高密度脂蛋白胆固醇、颈动脉粥样硬化

[1] Malekmohammad K,Bezsonov E E,Rafieian-Kopaei M.Role of Lipid Accumulation and Inflammation in Atherosclerosis:Focus on Molecular and Cellular Mechanisms[J].Front Cardiovasc Med,2021,8:707529. [2] Saba L,Cau R,Murgia A,et al.Carotid Plaque-RADS:A Novel Stroke Risk Classification System[J].JACC Cardiovasc Imaging,2024,17(1):62-75. [3] 丁天政,孙尚文.单核细胞/高密度脂蛋白比值与非ST段抬高型急性冠脉综合征及其严重程度关系研究[J].智慧健康, 2019, 5(01):46-48. [4] Libby P.Inflammation in atherosclerosis[J].Arterioscler Thromb Vasc Biol,2012,32(9):2045-2051. [5] Canpolat U,Cetin E H,Cetin S,et al.Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation[J].Clin Appl Thromb Hemost,2016,22(5):476-482. [6] Wang J,Tan G,Han L,et al.Novel biomarkers for cardiovascular risk prediction[J].J Geriatr Cardiol,2017,14(2):135-150. [7] Weber C,Shantsila E,Hristov M,et al.Role and analysis of monocyte subsets in cardiovascular disease.Joint consensus document of the European Society of Cardiology(ESC)Working Groups"Atherosclerosis&Vascular Biology"and"Thrombosis"[J].Thromb Haemost,2016, 116(4):626-637. [8] Spartalis M,Spartalis E,Athanasiou A,et al.The Role of the Endothelium in Premature Atherosclerosis:Molecular Mechanisms[J].Curr Med Chem,2020,27(7):1041-1051. [9] Kzhyshkowska J,Neyen C,Gordon S.Role of macrophage scavenger receptors in atherosclerosis[J].Immunobiology,2012,217(5):492-502. [10] Poznyak A V,Wu W,Melnichenko A A,et al.Signaling Pathways and Key Genes Involved in Regulation of foam Cell Formation in Atherosclerosis[J].Cells,2020,9(3). [11] Liu Z,Fan Q,Wu S,et al.Associations of Monocytes and the Monocyte/High-Density Lipoprotein Ratio With Extracranial and Intracranial Atherosclerotic Stenosis[J].Front Neurol,2021,12:756496. [12] Jaipersad A S,Shantsila A,Lip G Y H,et al.Expression of monocyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis[J].Ann Med,2014,46(7):530-538. [13] Ammirati E,Moroni F,Magnoni M,et al.Circulating CD14+and CD14(high)CD16-classical monocytes are reduced in patients with signs of plaque neovascularization in the carotid artery[J].Atherosclerosis,2016,255:171-178. [14] Westerterp M,Bochem A E,Yvan-Charvet L,et al.ATP-binding cassette transporters,atherosclerosis,and inflammation[J].Circ Res, 2014,114(1):157-170. [15] Kaplan I G,Kaplan M,Abacioglu O O,et al.Monocyte/HDL ratio predicts hypertensive complications[J].Bratisl Lek Listy, 2020, 121(2):133-136. [16] 张宁,刘文娴.高密度脂蛋白胆固醇与冠状动脉粥样硬化性心脏病及冠状动脉多支病变的相关性研究[J].中国医药, 2019, 14(07):969-972. [17] 刘巧林,曾宪容.尿酸/高密度脂蛋白胆固醇比值与颅内外动脉粥样硬化性狭窄的相关性[J].华西医学,2025,40(04):527-535. [18] 马福存,柏明见,王兵,等.小而密低密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值与颈动脉内膜中层厚度的关系[J].标记免疫分析与临床,2023,30(02):203-207. [19] Ammirati E,Bozzolo E P,Contri R,et al.Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus[J].Nutr Metab Cardiovasc Dis, 2014, 24(7):751-759. [20] Kanbay M,Solak Y,Unal H U,et al.Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease[J].Int Urol Nephrol,2014,46(8):1619-1625. [21] Ganjali S,Gotto A M J,Ruscica M,et al.Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases[J].J Cell Physiol,2018,233(12):9237-9246. [22] Cernaro V,Calabrese V,Loddo S,et al.Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein(HDL)ratio(MHR)in chronic kidney disease patients[J].Int Urol Nephrol,2022,54(9):2355-2364. [23] 蒋子裕,刘议蔓,周意君.MHR、PLR及血压变异性与高血压患者颈动脉粥样硬化的相关性分析[J].标记免疫分析与临床, 2024,31(05):880-884. [24] Zhang Z,Gao Y,Li Z,et al.Association of carotid atherosclerotic plaque and intima-media thickness with the monocyte to high-density lipoprotein cholesterol ratio among low-income residents of rural China:a population-based cross-sectional study[J].BMC Public Health, 2023,23(1):2541. [25] Gkantzios A,Tsiptsios D,Karapepera V,et al.Monocyte to HDL and Neutrophil to HDL Ratios as Potential Ischemic Stroke Prognostic Biomarkers[J].Neurol Int,2023,15(1):301-317. [26] Wang H,Shi W,Yi X,et al.Assessing the performance of monocyte to high-density lipoprotein ratio for predicting ischemic stroke:insights from a population-based Chinese cohort[J].Lipids Health Dis,2019,18(1):127. [27] Chen J W,Li C,Liu Z H,et al.The Role of Monocyte to High-Density Lipoprotein Cholesterol Ratio in Prediction of Carotid Intima-Media Thickness in Patients With Type 2 Diabetes[J].Front Endocrinol(Lausanne),2019,10:191. [28] 任娜娜.单核细胞与高密度脂蛋白胆固醇比值与2型糖尿病颈动脉粥样硬化病变的临床分析[D].大理大学,2023. [29] 薛舒红,朱婷,李华,等.MHR与老年2型糖尿病合并颈动脉粥样斑块的相关性研究[J].河南医学研究,2019,28(24):4436-4438. [30] 陈小会,李俊兰.单核细胞/高密度脂蛋白比值与绝经后女性颈动脉斑块Crouse评分的关系[J].重庆医学,2019,48(15):2583-2586. [31] 黄兴杰,夏中华,裴芳,等.单核细胞计数/高密度脂蛋白比值变化与原发性高血压患者合并颈动脉粥样硬化的关系[J].广西医学, 2020,42(13):1621-1624.

点击下载PDF